Oakworth Capital’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$53.9K Sell
683
-526
-44% -$42.4K ﹤0.01% 458
2026
Q1
$105K Sell
1,209
-146
-11% -$14K 0.01% 354
2025
Q4
$130K Buy
1,355
+153
+13% +$14.9K 0.01% 305
2025
Q3
$114K Buy
1,202
+300
+33% +$27.6K 0.01% 325
2025
Q2
$78.6K Sell
902
-241
-21% -$20.4K 0.01% 317
2025
Q1
$103K Hold
1,143
0.01% 292
2024
Q4
$91.3K Hold
1,143
0.01% 296
2024
Q3
$103K Sell
1,143
-52
-4% -$4.37K 0.01% 276
2024
Q2
$94.1K Sell
1,195
-729
-38% -$59.8K 0.01% 275
2024
Q1
$168K Buy
1,924
+468
+32% +$39.9K 0.01% 210
2023
Q4
$120K Buy
1,456
+101
+7% +$7.7K 0.01% 229
2023
Q3
$106K Sell
1,355
-487
-26% -$40.8K 0.01% 225
2023
Q2
$162K Buy
1,842
+96
+5% +$8.27K 0.01% 193
2023
Q1
$141K Sell
1,746
-1,855
-52% -$151K 0.01% 202
2022
Q4
$280K Buy
3,601
+69
+2% +$5.59K 0.03% 131
2022
Q3
$286K Sell
3,532
-100
-3% -$8.99K 0.03% 134
2022
Q2
$326K Sell
3,632
-1,626
-31% -$165K 0.03% 131
2022
Q1
$584K Sell
5,258
-269
-5% -$28.4K 0.05% 100
2021
Q4
$572K Sell
5,527
-388
-7% -$44.9K 0.05% 99
2021
Q3
$741K Buy
5,915
+700
+13% +$90.6K 0.07% 81
2021
Q2
$647K Buy
5,215
+102
+2% +$12.8K 0.06% 92
2021
Q1
$604K Buy
5,113
+14
+0.3% +$1.64K 0.07% 89
2020
Q4
$597K Sell
5,099
-95
-2% -$10.5K 0.08% 85
2020
Q3
$540K Buy
5,194
+57
+1% +$5.72K 0.09% 80
2020
Q2
$471K Buy
5,137
+1,990
+63% +$191K 0.08% 86
2020
Q1
$284K Buy
3,147
+1,285
+69% +$137K 0.07% 107
2019
Q4
$217K Buy
1,862
+1,184
+175% +$130K 0.04% 153
2019
Q3
$74K Sell
678
-2,314
-77% -$241K 0.01% 249
2019
Q2
$291K Buy
2,992
+205
+7% +$18.7K 0.06% 129
2019
Q1
$254K Hold
2,787
0.05% 142
2018
Q4
$253K Hold
2,787
0.06% 134
2018
Q3
$274K Hold
2,787
0.05% 142
2018
Q2
$238K Hold
2,787
0.05% 145
2018
Q1
$224K Sell
2,787
-15
-0.5% -$1.24K 0.05% 144
2017
Q4
$230K Sell
2,802
-100
-3% -$8.01K 0.05% 143
2017
Q3
$234K Hold
2,902
0.06% 142
2017
Q2
$258K Sell
2,902
-485
-14% -$40.9K 0.07% 129
2017
Q1
$273K Sell
3,387
-128
-4% -$10K 0.08% 120
2016
Q4
$257K Buy
3,515
+105
+3% +$8.25K 0.08% 127
2016
Q3
$295K Sell
3,410
-70
-2% -$6.1K 0.1% 104
2016
Q2
$280K Buy
3,480
+2,092
+151% +$169K 0.1% 107
2016
Q1
$104K Buy
1,388
+700
+102% +$52.7K 0.04% 164
2015
Q4
$53K Buy
688
+545
+381% +$41K 0.02% 186
2015
Q3
$10K Hold
143
0.01% 296
2015
Q2
$11K Hold
143
0.01% 294
2015
Q1
$11K Buy
+143
New +$10.8K 0.01% 309

Other funds holding MDT

Oakworth Capital's MDT Position: Q2 2026 in Review

Oakworth Capital reduced its Medtronic (MDT) stake by 44% in Q2 2026, selling an estimated $42.4K and leaving 683 shares worth $53.9K. The position accounts for ﹤0.01% of the portfolio, ranked #458.

Oakworth Capital first reported a position in MDT in Q1 2015 and has held it in 46 quarters since. The position peaked at $741K in Q3 2021. 673 funds tracked by Wall St. Rank hold MDT as of Q2 2026.

  • Oakworth Capital held 683 shares of Medtronic worth $53.9K as of Q2 2026.
  • Oakworth Capital sold 526 Medtronic shares in Q2 2026, an estimated $42.4K.
  • Medtronic made up ﹤0.01% of Oakworth Capital's portfolio in Q2 2026, its #458 holding.
  • Oakworth Capital first reported a position in Medtronic in Q1 2015 and has held it in 46 quarters since.
  • Oakworth Capital's Medtronic position peaked at $741K in Q3 2021.
  • 673 funds tracked by Wall St. Rank held Medtronic as of Q2 2026.

Based on Oakworth Capital's 13F filing for Q2 2026, filed 22 Jul 2026.